Do Not Treat Asymptomatic Bacteriuria with Staphylococcus epidermidis in This Patient
In an asymptomatic 13-year-old male with a Staphylococcus epidermidis-positive urine culture, antibiotic treatment should NOT be administered. This represents asymptomatic bacteriuria (ASB), and treatment is not indicated in the absence of symptoms or specific high-risk conditions.
Clinical Reasoning
Why No Treatment is Appropriate
The 2024 EAU guidelines 1 and recent evidence 2, 3, 4, 5 consistently demonstrate that asymptomatic bacteriuria should not be treated in most populations. Treatment of ASB is associated with:
- Increased antimicrobial resistance through selective pressure
- Higher rates of subsequent symptomatic infections with resistant organisms
- Adverse drug effects without clinical benefit
- Increased risk of Clostridioides difficile infection 3
The Staphylococcus epidermidis Context
While S. epidermidis is typically considered a skin contaminant when isolated from urine cultures 6, recent literature suggests it can occasionally be a true uropathogen in children with anatomic abnormalities or instrumentation history 7. However, this distinction only matters if the patient is symptomatic.
In your asymptomatic patient:
- The organism's pathogenic potential is irrelevant without clinical infection
- Treatment would not prevent future symptomatic UTI
- The culture likely represents colonization or contamination
Specific Exceptions Where Treatment WOULD Be Indicated
Treatment of ASB is recommended ONLY in these two scenarios 2, 3, 5:
- Pregnancy - to prevent pyelonephritis and adverse pregnancy outcomes
- Before invasive urological procedures - to prevent post-procedural bacteremia and sepsis
Your 13-year-old male patient does not meet either criterion.
What You Should Do Instead
Immediate Management
- Do not prescribe antibiotics
- Reassure the patient and family that bacteria in urine without symptoms does not require treatment
- Document clearly that this represents ASB and treatment was appropriately withheld
Evaluate for Underlying Risk Factors
While treatment is not indicated, consider whether this patient has factors that might explain the positive culture 7:
- History of urological instrumentation (catheterization, cystoscopy)
- Anatomic abnormalities (posterior urethral valves, vesicoureteral reflux)
- Neurogenic bladder or incomplete voiding
- Recent urological procedures
If any of these are present, consider renal/bladder ultrasound to evaluate anatomy, but this does not change the decision to withhold antibiotics for ASB.
Common Pitfalls to Avoid
The "Positive Culture Must Be Treated" Fallacy
The most common error is reflexively treating any positive urine culture 4. Urine cultures should only be obtained in symptomatic patients or those meeting specific screening criteria (pregnancy, pre-procedure). Obtaining cultures in asymptomatic patients leads to unnecessary treatment.
Misinterpreting Male Gender as a Risk Factor
The 2024 EAU guidelines 1 list "urinary tract infection in males" as a factor associated with complicated UTI, but this applies to symptomatic infections, not ASB. Male gender alone does not justify treating asymptomatic bacteriuria.
Concern About S. epidermidis Specifically
The 1995 HICPAC guidelines 6 specifically discourage vancomycin treatment for single positive blood cultures with coagulase-negative staphylococci when contamination is likely. This principle extends to urine cultures—S. epidermidis in asymptomatic patients should not trigger treatment regardless of the organism.
When to Reassess
Instruct the patient/family to return if symptoms develop:
- Dysuria (painful urination)
- Frequency or urgency
- Fever
- Flank pain
- Suprapubic pain
If symptomatic UTI develops, obtain a repeat culture and treat based on symptoms and susceptibilities, with treatment duration of 7-14 days for males when prostatitis cannot be excluded 1.
Performance Measure Consideration
Not treating ASB should be considered a quality metric 4. Appropriate withholding of antibiotics in this scenario represents good antimicrobial stewardship and adherence to evidence-based guidelines 5.